Kure Therapeutics Inc share price logo

Kure Therapeutics Inc Share Price

NASDAQ: OKUR

Small Cap

$3.28

-0.05

(-1.50%)

Live

as on

Kure Therapeutics Inc Stock Performance

as on October 29, 2025 at 7:46 pm IST

  • Day's Low

    Day's High

    $3.27
    $3.37
    downward going graph

    0.30%

    Downside

    2.74%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.7
    $17.9
    downward going graph

    48.17%

    Downside

    445.73%

    Upside

    downward going graph

Kure Therapeutics Inc share price movements today

Previous Close
$3.33
Open
$3.32
Volume
7.7K
Day's Low - High
$3.27 - $3.37
52 Week Low - High
$1.7 - $17.9

Kure Therapeutics Inc Historical Returns

1 Month Return
+ 24.72 %
3 Month Return
+ 47.35 %
1 Year Return
-81.37 %
3 Year Return
0 %
5 Year Return
0 %

Kure Therapeutics Inc Stock Fundamentals & Key Indicators

Check Kure Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.3M

EPS (TTM)

-4.572

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-142.90%

Kure Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kure Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$48.3MNANA0.00%
BUY$62.7B285.91%-505.15-12.96%
NA$36.5BNANA-3.89%
BUY$108.0B104.04%29.9531.86%
BUY$62.0B17.76%14.7531.37%

Stock Returns calculator for Kure Therapeutics Inc Stock including INR - Dollar returns

The Kure Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Kure Therapeutics Inc investment value today

Current value as on today

₹23,416

Returns

₹76,584

(-76.58%)

Returns from Kure Therapeutics Inc Stock

₹81,645 (-81.65%)

Dollar Returns*

₹5,061 (+5.06%)

Kure Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Kure Therapeutics Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Kure Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
0
0
0
0
0
0
0
Operating Income
-8
-8
-20
21
-9
-14
-4
-33
-17
-16
EBITDA
-8
-8
-39
21
-9
-13
3
-31
-16
-15
Interest Expense
-
-
-
-
-
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-8
-19
18
-9
-14
-3
-35
-15
-15
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-8
-19
18
-9
-14
-3
-35
-15
-15
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kure Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
0
0
0
Operating Income
-29
-36
-54
EBITDA
-29
-34
-51
Interest Expense
-
-
0
Depreciation
0
0
0
Income Before Tax
-29
-35
-52
Income Tax Expense
-
-
-
Net Income
-29
-35
-52
Net Profit Margin
0.00%
0.00%
0.00%

Kure Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-8
-36
18
-9
-14
6
-35
-15
-15
Operating Cash Flow
-11
-18
9
-10
-6
-2
-21
-14
-13
Investing Cash Flow
0
21
29
0
0
25
-45
0
0
Financing Cash Flow
0
0
-11
0
5
2
114
0
-
Change in Cash
-11
2
18
-10
0
24
50
-14
-13

Kure Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-39
-29
-35
-52
Operating Cash Flow
-37
-26
-34
-51
Investing Cash Flow
-23
-1
0
15
Financing Cash Flow
132
26
53
116
Change in Cash
71
-1
18
80

Insights on Kure Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, OKUR stock has moved up by 14.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 132.7% return, outperforming this stock by 222.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.2% return, outperforming this stock by 148.6%

About Kure Therapeutics Inc

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Company is building a pipeline of tumor-agnostic candidates. It is developing OKI-219, a selective PI3KaH1047R inhibitor, as its lead program. It is engaged in targeting oncogenic PI3Ka and has multiple programs designed to enable targeting of this key oncogene. It is focused on delivering highly selective drug candidates that preserve wild-type PI3Ka while targeting the PI3Ka-mutated cancers, initially in advanced breast cancer. Its lead product candidate, OKI-219, is advancing in a phase I clinical trial. It also focuses on a development candidate targeting the most common PI3Ka mutations, such as H1047R, E545K, and E542K. Additionally, it is developing an allosteric inhibitor molecule.
OrganisationKure Therapeutics Inc
Headquarters6707 Winchester Circle, Boulder, CO, United States, 80301
CEODr. Nicholas A. Saccomano Ph.D.
E-voting on sharesClick here to vote

Key Management of Kure Therapeutics Inc

Name

Title

Mr. Jason A. Leverone CPA

Chief Financial Officer

Dr. Dylan Hartley Ph.D.

Chief Scientific Officer

Mr. Rogan P. Nunn J.D.

General Counsel & Secretary

Dr. Kevin S. Litwiler Ph.D.

Senior Vice President of DMPK & Clinical Pharmacology

Dr. Nicholas A. Saccomano Ph.D.

President, CEO & Director

Dr. Samuel Agresta M.D., M.P.H.

Chief Medical Officer

Dr. James Blake Ph.D.

Senior Vice President of Computational Drug Discovery

Dr. Mark L. Boys Ph.D.

Senior Vice President of Discovery Chemistry

Ms. Roberta Alton

Senior VP of Clinical Operations

FAQs

What is Kure Therapeutics Inc share price today?

Kure Therapeutics Inc share price today is $3.28 as on . Kure Therapeutics Inc share today touched a day high of $3.37 and a low of $3.27.

What is the 52 week high and 52 week low for Kure Therapeutics Inc share?

Kure Therapeutics Inc share touched a 52 week high of $17.9 on and a 52 week low of $1.7 on . Kure Therapeutics Inc stock price today i.e. is trending at $3.28,which is 81.68% down from its 52 week high and 92.94% up from its 52 week low.

What is Kure Therapeutics Inc's market capitalisation today?

Kure Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Kure Therapeutics Inc Stock (OKUR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kure Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kure Therapeutics Inc Shares that will get you 0.4573 shares as per Kure Therapeutics Inc share price of $3.28 per share as on October 29, 2025 at 7:46 pm IST.

What is the minimum amount required to buy Kure Therapeutics Inc Stock (OKUR) from India?

Indian investors can start investing in Kure Therapeutics Inc (OKUR) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Kure Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kure Therapeutics Inc share’s latest price of $3.28 as on October 29, 2025 at 7:46 pm IST, you will get 3.0488 shares of Kure Therapeutics Inc. Learn more about fractional shares .